Advertisement
Screener

Insight Molecular Diagnostics Inc. (IMDX) Increase (Decrease) in Accounts Payable and Accrued Liabilities

Insight Molecular Diagnostics Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities

Insight Molecular Diagnostics Inc. (IMDX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$1.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-10

  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$1.10M.
  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$105.00K, a 110.22% decline year-over-year.
  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $3.56M, a 404.97% increase year-over-year.
  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $1.18M, a 81.36% increase year-over-year.
  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $2.65M, a 173.63% increase from fiscal 2024.
  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $967.00K.
  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$4.76M, a 1701.68% decline from fiscal 2022.
  • Insight Molecular Diagnostics Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $297.00K.
Period endIncrease (Decrease) in Accounts Payable and Accrued Liabilities 3 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 6 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 9 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 12 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed
2026-06-30-$1.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
-$1.21M
10-Q · filed 2026-08-10
$2.35M
derived: sum of 3 quarters · filed 2026-08-10
$3.52M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31-$105.00K
10-Q · filed 2026-05-13
$3.45M
derived: sum of 2 quarters · filed 2026-05-13
$4.63M
derived: sum of 3 quarters · filed 2026-05-13
$1.51M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31$3.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$4.73M
derived: sum of 2 quarters · filed 2026-03-26
$1.62M
derived: sum of 3 quarters · filed 2026-08-10
$2.65M
10-K · filed 2026-03-26
2025-09-30$1.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$1.94M
derived: sum of 2 quarters · filed 2026-08-10
-$909.00K
10-Q · filed 2025-11-10
-$205.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30-$3.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
-$2.09M
10-Q · filed 2026-08-10
-$1.38M
derived: sum of 3 quarters · filed 2026-08-10
-$733.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31$1.03M
10-Q · filed 2026-05-13
$1.73M
derived: sum of 2 quarters · filed 2026-05-13
$2.38M
derived: sum of 3 quarters · filed 2026-05-13
$1.14M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$704.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$1.35M
derived: sum of 2 quarters · filed 2026-03-26
$113.00K
derived: sum of 3 quarters · filed 2026-03-26
$967.00K
10-K · filed 2026-03-26
2024-09-30$649.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$591.00K
derived: sum of 2 quarters · filed 2025-11-10
$263.00K
10-Q · filed 2025-11-10
-$301.00K
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30-$1.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
-$386.00K
10-Q · filed 2025-08-11
-$950.00K
derived: sum of 3 quarters · filed 2025-08-11
-$824.00K
derived: sum of 4 quarters · filed 2025-08-11
2024-03-31$854.00K
10-Q · filed 2025-05-12
$290.00K
derived: sum of 2 quarters · filed 2025-05-12
$416.00K
derived: sum of 3 quarters · filed 2025-05-12
-$1.24M
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31-$564.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24
-$438.00K
derived: sum of 2 quarters · filed 2025-03-24
-$2.10M
derived: sum of 3 quarters · filed 2025-03-24
-$4.76M
10-K · filed 2025-03-24
2023-09-30$126.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$1.53M
derived: sum of 2 quarters · filed 2024-11-12
-$4.19M
10-Q · filed 2024-11-12
-$4.32M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$1.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$4.32M
10-Q · filed 2024-08-08
-$4.44M
derived: sum of 3 quarters · filed 2024-08-08
-$4.26M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$2.66M
10-Q · filed 2024-05-15
-$2.79M
derived: sum of 2 quarters · filed 2024-05-15
-$2.60M
derived: sum of 3 quarters · filed 2024-05-15
-$2.34M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$125.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
$58.00K
derived: sum of 2 quarters · filed 2024-04-16
$318.00K
derived: sum of 3 quarters · filed 2024-04-16
$297.00K
10-K · filed 2024-04-16
2022-09-30$183.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$443.00K
derived: sum of 2 quarters · filed 2023-11-09
$422.00K
10-Q · filed 2023-11-09
$666.00K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$260.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$239.00K
10-Q · filed 2023-08-10
$483.00K
derived: sum of 3 quarters · filed 2023-08-10
-$343.00K
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$21.00K
10-Q · filed 2023-05-15
$223.00K
derived: sum of 2 quarters · filed 2023-05-15
-$603.00K
derived: sum of 3 quarters · filed 2023-05-15
-$1.77M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$244.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12
-$582.00K
derived: sum of 2 quarters · filed 2023-04-12
-$1.75M
derived: sum of 3 quarters · filed 2023-04-12
-$1.35M
10-K · filed 2023-04-12
2021-09-30-$826.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
-$2.00M
derived: sum of 2 quarters · filed 2022-11-10
-$1.59M
10-Q · filed 2022-11-10
-$2.59M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$1.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
-$766.00K
10-Q · filed 2022-08-12
-$1.76M
derived: sum of 3 quarters · filed 2022-08-12
-$982.00K
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$405.00K
10-Q · filed 2022-05-12
-$590.00K
derived: sum of 2 quarters · filed 2022-05-12
$189.00K
derived: sum of 3 quarters · filed 2022-05-12
$6.00K
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$995.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
-$216.00K
derived: sum of 2 quarters · filed 2022-03-11
-$399.00K
derived: sum of 3 quarters · filed 2022-03-11
$848.00K
10-K · filed 2022-03-11
$854.00K
10-K · filed 2021-03-19
2020-09-30$779.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$596.00K
derived: sum of 2 quarters · filed 2021-11-09
$1.84M
10-Q · filed 2021-11-09
$3.00M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30-$183.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
$1.06M
10-Q · filed 2021-08-11
$2.22M
derived: sum of 3 quarters · filed 2021-08-11
$1.04M
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$1.25M
10-Q · filed 2021-05-17
$2.40M
derived: sum of 2 quarters · filed 2021-05-17
$1.22M
derived: sum of 3 quarters · filed 2021-05-17
$2.46M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$1.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19
-$26.00K
derived: sum of 2 quarters · filed 2021-03-19
$1.21M
derived: sum of 3 quarters · filed 2021-03-19
$741.00K
10-K · filed 2021-03-19
2019-09-30-$1.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$52.00K
derived: sum of 2 quarters · filed 2020-11-12
-$416.00K
10-Q · filed 2020-11-12
$625.00K
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$1.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29
$767.00K
10-Q · filed 2020-07-29
$1.81M
derived: sum of 3 quarters · filed 2020-07-29
$1.77M
derived: sum of 4 quarters · filed 2020-07-29
2019-03-31-$468.00K
10-Q · filed 2020-05-12
$573.00K
derived: sum of 2 quarters · filed 2020-05-12
$533.00K
derived: sum of 3 quarters · filed 2020-05-12
-$465.00K
derived: sum of 4 quarters · filed 2020-05-12
2018-12-31$1.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
$1.00M
derived: sum of 2 quarters · filed 2020-03-26
$3.00K
derived: sum of 3 quarters · filed 2020-03-26
$1.00M
10-K · filed 2020-03-26
2018-09-30-$40.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
-$1.04M
derived: sum of 2 quarters · filed 2019-11-14
-$39.00K
10-Q · filed 2019-11-14
-$314.00K
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30-$998.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$1.00K
10-Q · filed 2019-08-14
-$274.00K
derived: sum of 3 quarters · filed 2019-08-14
-$108.00K
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$999.00K
10-Q · filed 2019-05-14
$724.00K
derived: sum of 2 quarters · filed 2019-05-14
$890.00K
derived: sum of 3 quarters · filed 2019-05-14
$851.00K
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31-$275.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
-$109.00K
derived: sum of 2 quarters · filed 2019-04-01
-$148.00K
derived: sum of 3 quarters · filed 2019-04-01
-$48.00K
10-K · filed 2019-04-01
2017-09-30$166.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
$127.00K
derived: sum of 2 quarters · filed 2018-11-13
$227.00K
10-Q · filed 2018-11-13
-$92.00K
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30-$39.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
$61.00K
10-Q · filed 2018-08-14
-$258.00K
derived: sum of 3 quarters · filed 2018-08-14
$580.00K
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$100.00K
10-Q · filed 2018-05-15
-$219.00K
derived: sum of 2 quarters · filed 2018-05-15
$619.00K
derived: sum of 3 quarters · filed 2018-05-15
$514.00K
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31-$319.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
$519.00K
derived: sum of 2 quarters · filed 2018-04-02
$414.00K
derived: sum of 3 quarters · filed 2018-04-02
$229.00K
10-K · filed 2018-04-02
2016-09-30$838.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$733.00K
derived: sum of 2 quarters · filed 2017-11-14
$548.00K
10-Q · filed 2017-11-14
$1.31M
derived: sum of 4 quarters · filed 2018-04-02
2016-06-30-$105.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
-$290.00K
10-Q · filed 2017-08-14
$477.00K
derived: sum of 3 quarters · filed 2018-04-02
$768.00K
derived: sum of 4 quarters · filed 2018-04-02
2016-03-31-$185.00K
10-Q · filed 2017-04-28
$582.00K
derived: sum of 2 quarters · filed 2018-04-02
$873.00K
derived: sum of 3 quarters · filed 2018-04-02
$1.05M
derived: sum of 4 quarters · filed 2018-04-02
2015-12-31$767.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
$1.06M
derived: sum of 2 quarters · filed 2018-04-02
$1.23M
derived: sum of 3 quarters · filed 2018-04-02
$1.04M
10-K · filed 2018-04-02
2015-09-30$291.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$467.00K
derived: sum of 2 quarters · filed 2016-11-10
$275.00K
10-Q · filed 2016-11-10
2015-06-30$176.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
-$16.00K
10-Q · filed 2016-08-11
2015-03-31-$192.00K
10-Q · filed 2016-05-16
2014-12-31$291.00K
10-K · filed 2017-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92